Blood cancers, Chronic leukaemia, Chronic lymphocytic leukaemia (CLL), High grade lymphoma, Leukaemia, Lymphoma, Non-Hodgkin lymphoma (NHL)
Open
Phase 2
This trial is looking at acalabrutinib to see if it can improve treatment for people with Richter’s syndrome.
Chronic lymphocytic leukaemia (CLL) can sometimes develop into a condition called Richter’s syndrome. Richter's syndrome is a type of non-Hodgkin lymphoma (NHL).
Recruitment start: 23 July 2019
Recruitment end: 31 December 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Toby Eyre
Blood Cancer UK
Trials Acceleration Program (TAP)
Acerta Pharma
University of Birmingham
Last reviewed: 14 July 2025
CRUK internal database number: 16164
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
